Marsha H. Fanucci
Independent DirectorMs. Marsha H. Fanucci, MBA, had been an Independent Director of Syros Pharmaceuticals, Inc. since October 19, 2015 until February 28, 2025. She was a Director at Forma Therapeutics Holdings, Inc. since October 2014 until October 14, 2022. She had been a Director of Alnylam Pharmaceuticals, Inc. since December 2010 until September 29, 2023. She has been Director of FORMA Therapeutics, Inc. since October 2014. She has been an Independent Director at Generate Biomedicines, Inc. since March 2025. Since 2009, Ms. Fanucci has been an independent consultant for private and publicly traded biotechnology companies. Ms. Fanucci was Chairman of Cyclerion Therapeutics, Inc. from April 1, 2019 to May 15, 2023 and had been its Independent Director since March 2019 until May 15, 2023. Ms. Fanucci served as Senior Vice President and Chief Financial Officer of Millennium Pharmaceuticals Inc., since July 2004 until January 2009 and also served as Principal Accounting Officer. She served as Senior Vice President of Finance and Corporate Strategy at Millennium Pharmaceuticals Inc. from October 2003 to July 2004 and served as its Vice President of Finance and Corporate Strategy from July 2003 to June 2004 and Vice President of Corporate Development from July 2000 to July 2003. From 2000 to 2009, Ms. Fanucci served at Millennium Pharmaceuticals in a number of executive leadership positions. Ms. Fanucci contributed to a series of strategic processes, advanced investment-stage Millennium to profitability and was instrumental in the acquisition by Takeda Pharmaceutical Company in 2008. Ms. Fanucci served as Vice President of Corporate Development and Strategy at Genzyme Corp. (now Sanofi Genzyme, the specialty care global business unit of Sanofi), from 1998 to 2000. She held senior management positions at Arthur D. Little Inc., including Vice President, Managing Director and Director. She served as a Director of Ironwood Pharmaceuticals, Inc. since October 2009 until April 1, 2019. Ms. Fanucci served as an Independent Director of Momenta Pharmaceuticals Inc. since March 16, 2005 until December 31, 2016. Ms. Fanucci received her Bachelor of Science degree in Pharmacy from West Virginia University and her Masters in Business Administration from Northeastern University.
公司職務
- 公司名稱Generate Biomedicines, Inc.股票代碼GENB職務Independent Director
